SPECIALITY MEDICINES LIMITED
SPML · NSEon the next trading day
Valuation
Blended fair value using DCF and peer comparison methods.
See if SPECIALITY MEDICINES LIMITED is undervalued
Unlock intrinsic value for 4,800+ Indian stocks — free.
Sign in or create free accountThe intrinsic value shown is an algorithmic estimate based on publicly available financial data — including DCF analysis, peer comparison, and historical financials. It is not a research report, investment advice, or a recommendation to buy, sell, or hold any security. Stock valuations involve uncertainty and may differ significantly from market prices. Please consult a SEBI-registered investment adviser before making any investment decision.
Peer comparison
How this company stacks up against sector peers on valuation and quality metrics.
Branded generics & specialty pharma · 8 peers · sector medians shown
| Company | Mkt Cap | P/E | P/B | EV/EBITDA | ROE | Net Margin | Rev CAGR 3y |
|---|---|---|---|---|---|---|---|
SPECIALITY MEDICINES LIMITED SPML · you | ₹143 Cr | 17.4× | — | — | — | — | — |
| Sector median | — | 23.3× | 2.5× | 13.1× | 11.6% | 6.4% | 13.7% |
| Fermenta Biotech Limited FERMENTA | ₹1,325 Cr | 14.5× | 2.5× | 11.6× | 17.7% | 13.7% | 14.5% |
| Lincoln Pharmaceuticals Limited LINCOLN | ₹1,272 Cr | 14.3× | 1.7× | 13.1× | 11.6% | 13.1% | 9.6% |
| Themis Medicare Limited THEMISMED | ₹964 Cr | 32.2× | 3.0× | — | 9.2% | 0.3% | — |
| Shree Ganesh Remedies Limited SGRL | ₹629 Cr | 40.8× | 4.7× | — | 11.6% | 0.1% | — |
| Kilitch Drugs (India) Limited KILITCH | ₹599 Cr | 19.9× | 2.1× | 18.8× | 10.8% | 12.8% | 19.0% |
| Aptus Pharma Limited APPL | ₹452 Cr | 97.9× | — | — | — | — | — |
| Anuh Pharma Limited ANUHPHR | ₹419 Cr | 18.8× | 2.2× | 5.4× | 11.7% | 5.3% | 13.5% |
| Medico Remedies Limited MEDICO | ₹352 Cr | 26.8× | 4.7× | 21.6× | 17.4% | 6.4% | 13.7% |
SPECIALITY trades at a discount to sector peers on P/E (17.4× vs median 23.3×). This may signal undervaluation — or reflect lower expected growth or higher perceived risk versus the peer group.
Business quality
Valuation
Returns
Growth
Efficiency
Liquidity & Solvency
Financial health
Piotroski F-Score, Altman Z-Score, and key solvency ratios.
Full financial data
Charts and annual statements for income, balance sheet and cash flow.
Income trend
Revenue, profit and margin trends over time.
Cash flow
Where cash comes from and where it goes.
Balance sheet
Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.